Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers

ERYILMAZ, AYLİN; Başal, Yeşim

doi:10.4274/meandros.galenos.2016.2781

Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers

Aylin ERYILMAZ, (Aydın Adnan Menderes Üniversitesi, Tıp Fakültesi, Kulak Burun Boğaz Anabilim Dalı, Aydın, Türkiye)

Yeşim BASAL (Aydın Adnan Menderes Üniversitesi, Tıp Fakültesi, Kulak Burun Boğaz Anabilim Dalı, Aydın, Türkiye)

Meandros Medical And Dental Journal

0 0

Yıl: 2020 Cilt: 21 Sayı: 2 Sayfa Aralığı: 98 - 103 Metin Dili: İngilizce DOI: 10.4274/meandros.galenos.2016.2781 İndeks Tarihi: 06-05-2021

Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers

Öz:

There are numerous controversial issues in the management of patients with N0 neck. Whether the diagnosis of N0 neck should be made based on the physical examination or imaging methods is contradictory in the first place. The rates of metastasis to the neck and the identification of occult neck metastasis vary according to the location and histopathological characteristics of the primary tumour. A wait-and-see approach may be preferred in the treatment of these patients, whereas an elective neck dissection or elective radiotherapy may be implemented considering all these features. An elective treatment is preferred if the occult metastasis ratio is higher than 15-20%. The neck dissection levels change depending on the primary tumour localisation. In patients with N0 neck, it is required to decide on the most effective prophylactic treatment with low morbidity that can avoid cervical recurrence and distant metastasis.

Anahtar Kelime:

Baş Boyun Kanserlerinde, N0 Boyuna Yaklaşımda Fikir Ayrılıkları ve Nedenleri

Öz:

Baş boyun kanserlerinde, N0 boyunlu hastalara yaklaşımda birçok tartışmalı konubulunmaktadır. Başta N0 tanısının, muayeneye göre mi, görüntüleme yöntemlerinegöre mi konulacağı tartışmalıdır. Primer tümörün yerleşim yerine ve histopatolojiközelliklerine göre boyuna metastaz yapma ve boyunda okült metastaz saptanmaoranları değişmektedir. Tüm bu özellikler gözetilerek, bu hastaların tedavisinde,bekle-gör şeklinde bir yaklaşım olabildiği gibi, elektif boyun diseksiyonu veyaelektif radyoterapi de uygulanabilmektedir. Boyunda gizli metastaz olasılığı %15- 20’nin üzerinde ise elektif tedavi önerilmektedir. Elektif boyun diseksiyonlarındaprimer tümöre göre diseke edilecek lenf nodu bölgeleri değişmektedir. N0 olanhastalarda, boyun nüksü ve uzak metastazdan koruyan en etkin ve morbiditesidüşük profilaktik tedaviye karar vermek gerekmektedir

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Pillsbury HC, Clark M. A rationale for therapy of the N0 neck. Laryngoscope 1997; 107: 1294-315.
2. de Bree R, Takes RP, Castelijns JA, Medina JE, Stoeckli SJ, Mancuso AA, et al. Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma. Head Neck 2015; 37: 1829-39.
3. Flach GB, Tenhagen M, de Bree R, Brakenhoff RH, van der Waal I, Bloemena E, et al. Outcome of patients with early stage oral cancer managed by an observation strategy towards the N0 neck using ultrasound guided fine needle aspiration cytology: No survival difference as compared to elective neck dissection. Oral Oncol 2013; 49: 157-64.
4. Nguyen A, Luginbuhl A, Cognetti D, Abel KV, Bar-Ad V, Intenzo C, et al. Effectiveness of PET/CT in the preoperative evaluation of neck disease. Laryngoscope 2014; 124: 159-64.
5. Levent Erişen. Baş Boyun Kanserleri. Baş Boyun Kanserlerinde Boyuna Yaklaşım. 2003 Nobel; 439-502.
6. Fasunla AJ, Greene BH, Timmesfeld N, Wiegand S, Werner JA, Sesterhenn AM. A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol 2011; 47: 320-4.
7. Huang SF, Chang JT, Liao CT, Jan Kang C, Lin CY, Fan KH, et al. The role of elective neck dissection in early stage buccal cancer. Laryngoscope 2015; 125: 128-33.
8. Chow JM, Levin BC, Krivit JS, Applebaum EL. Radiotherapy or surgery for subclinical cervical node metastases. Arch Otolaryngol Head Neck Surg 1989; 115: 981-4.
9. Al-Rajhi N, Khafaga Y, El-Husseiny J, Saleem M, Mourad W, Al-Otieschan A, et al. Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol 2000; 36: 508-14.
10. Ebrahimi A, Ashford BG, Clark JR. Improved survival with elective neck dissection in thick early-stage oral squamous cell carcinoma. Head Neck 2012; 34: 709-16.
11. Po Wing Yuen A, Lam KY, Lam LK, Ho CM, Chow TL, Yuen WF, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma-A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, MartinezGimeno score, and pathologic features. Head Neck 2002; 24: 513-20.
12. Koss SL, Russell MD, Leem TH, Schiff BA, Smith RV. Occult nodal disease in patients with failed laryngeal preservation undergoing surgical salvage. Laryngoscope 2014; 124: 421-8.
13. Ma H, Lian M, Feng L, Li P, Hou L, Liu H, et al. Management of cervical lymph nodes for cN0 advanced glottic laryngeal carcinoma and its long-term results. Acta Otolaryngol 2014; 134: 952-8.
14. An SY, Jung EJ, Lee M, Kwon TK, Sung MW, Jeon YK, et al. Factors related to regional recurrence in early stage squamous cell carcinoma of the oral tongue. Clin Exp Otorhinolaryngol 2008; 1: 166-70.
15. Altinyollar H, Bulut H, Berberoglu U. Is suprahyoid dissection a diagnostic operation in lower lip carcinoma? J Exp Clin Cancer Res 2002; 21: 29-30.
16. Peng KA, Chu AC, Lai C, Grogan T, Elashoff D, Abemayor E, et al. Is there a role for neck dissection in T1 oral tongue squamous cell carcinoma? The UCLA experience. Am J Otolaryngol 2014; 35: 741-6.
17. Ünsal Tuna EE, Özdem C. T1-T3 N0 oral dil kanserlerinde boyun lenfatik bölgelerinde metastazın araştırılması. Kbb-forum 2009; 8.
18. Iqbal H, Bhatti AB, Hussain R, Jamshed A. Regional failures after selective neck dissection in previously untreated squamous cell carcinoma of oral cavity. Int J Surg Oncol 2014; 2014: 205715.
19. Ord RA. Surgical management of the N0 neck in early stage T1-2 oral cancer; a personal perspective of early and late impalpable disease. Oral Maxillofac Surg 2012; 16: 181-8.
20. Chinn SB, Spector ME, Bellile EL, McHugh JB, Gernon TJ, Bradford CR, et al. Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg 2013; 149: 893-9.
21. Yılmaz T, Süslü N, Atay G, Günaydın RÖ, Bajin MD, Özer S. The effect of midline crossing of lateral supraglottic cancer on contralateral cervical lymph node metastasis. Acta Otolaryngol 2015; 135: 484-8.
22. Guney E, Yigitbasi OG. Functional surgical approach to the level I for staging early carcinoma of the lower lip. Otolaryngol Head Neck Surg 2004; 131: 503-8.
23. Ebrahim AK, Loock JW, Afrogheh A, Hille J. Is it oncologically safe to leave the ipsilateral submandibular gland during neck dissection for head and neck squamous cell carcinoma? J Laryngol Otol 2011; 125: 837-40.
24. Lanzer M, Gander T, Lübbers HT, Metzler P, Bredell M, Reinisch S. Preservation of ipsilateral submandibular gland is ill advised in cancer of the floor of the mouth or tongue. Laryngoscope 2014; 124: 2070-4.
25. Basheeth N, O’Leary G, Sheahan P. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome. JAMA Otolaryngol Head Neck Surg 2013; 139: 790-6.
26. Elsheikh MN, Ferlito A, Rinaldo A, Shaha AR, Khafif A, Coskun HH, et al. Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck? J Am Coll Surg 2006; 202: 320-3.
27. Lim YC, Koo BS, Lee JS, Lim JY, Choi EC. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck. Laryngoscope 2006; 116: 1148-52.
28. Coskun HH, Erisen L, Basut O. Selective neck dissection for clinically N0 neck in laryngeal cancer: is dissection of level IIb necessary? Otolaryngol Head Neck Surg 2004; 131: 655-9.
29. Gross BC, Olsen SM, Lewis JE, Kasperbauer JL, Moore EJ, Olsen KD, et al. Level IIB lymph node metastasis in laryngeal and hypopharyngeal squamous cell carcinoma: single-institution case series and review of the literature. Laryngoscope 2013; 123: 3032-6.
30. Maher NG, Hoffman GR. Elective neck dissection for primary oral cavity squamous cell carcinoma involving the tongue should include sublevel IIb. J Oral Maxillofac Surg 2014; 72: 2333-43.
31. Lim CM, Gilbert M, Johnson JT, Kim S. Is level V neck dissection necessary in primary parotid cancer? Laryngoscope 2015; 125: 118-21.
32. Schmalbach CE, Bradford CR. Is sentinel lymph node biopsy the standard of care for cutaneous head and neck melanoma? Laryngoscope 2015; 125: 153-60.
33. Flach GB, Bloemena E, Klop WM, van Es RJJ, Schepman KP, Hoekstra OS, et al. Sentinel lymph node biopsy in clinically N0 T1-T2 staged oral cancer: the Dutch multicenter trial. Oral Oncol 2014; 50: 1020-4.

APA	ERYILMAZ A, Başal Y (2020). Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. , 98 - 103. 10.4274/meandros.galenos.2016.2781
Chicago	ERYILMAZ AYLİN,Başal Yeşim Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. (2020): 98 - 103. 10.4274/meandros.galenos.2016.2781
MLA	ERYILMAZ AYLİN,Başal Yeşim Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. , 2020, ss.98 - 103. 10.4274/meandros.galenos.2016.2781
AMA	ERYILMAZ A,Başal Y Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. . 2020; 98 - 103. 10.4274/meandros.galenos.2016.2781
Vancouver	ERYILMAZ A,Başal Y Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. . 2020; 98 - 103. 10.4274/meandros.galenos.2016.2781
IEEE	ERYILMAZ A,Başal Y "Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers." , ss.98 - 103, 2020. 10.4274/meandros.galenos.2016.2781
ISNAD	ERYILMAZ, AYLİN - Başal, Yeşim. "Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers". (2020), 98-103. https://doi.org/10.4274/meandros.galenos.2016.2781

APA	ERYILMAZ A, Başal Y (2020). Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. Meandros Medical And Dental Journal, 21(2), 98 - 103. 10.4274/meandros.galenos.2016.2781
Chicago	ERYILMAZ AYLİN,Başal Yeşim Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. Meandros Medical And Dental Journal 21, no.2 (2020): 98 - 103. 10.4274/meandros.galenos.2016.2781
MLA	ERYILMAZ AYLİN,Başal Yeşim Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. Meandros Medical And Dental Journal, vol.21, no.2, 2020, ss.98 - 103. 10.4274/meandros.galenos.2016.2781
AMA	ERYILMAZ A,Başal Y Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. Meandros Medical And Dental Journal. 2020; 21(2): 98 - 103. 10.4274/meandros.galenos.2016.2781
Vancouver	ERYILMAZ A,Başal Y Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. Meandros Medical And Dental Journal. 2020; 21(2): 98 - 103. 10.4274/meandros.galenos.2016.2781
IEEE	ERYILMAZ A,Başal Y "Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers." Meandros Medical And Dental Journal, 21, ss.98 - 103, 2020. 10.4274/meandros.galenos.2016.2781
ISNAD	ERYILMAZ, AYLİN - Başal, Yeşim. "Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers". Meandros Medical And Dental Journal 21/2 (2020), 98-103. https://doi.org/10.4274/meandros.galenos.2016.2781